{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:26:24Z","timestamp":1787005584864,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"34","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,8]]},"DOI":"10.1038\/s41388-026-03867-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:01:11Z","timestamp":1783908071000},"page":"3497-3510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7\/DNA2 axis and mitophagy regulation"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-0112","authenticated-orcid":false,"given":"Ruifeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qintao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-951X","authenticated-orcid":false,"given":"Bingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0660-9162","authenticated-orcid":false,"given":"Wenhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0126-197X","authenticated-orcid":false,"given":"Kun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-1626","authenticated-orcid":false,"given":"Fangning","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-3780","authenticated-orcid":false,"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"3867_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3867_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB. Prostate cancer: a review. JAMA. 2025;333:1433\u201346.","journal-title":"JAMA"},{"key":"3867_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s44178-024-00118-4","volume":"3","author":"B Dai","year":"2024","unstructured":"Dai B, Wang H, Shi B, Xing J, Zhu S, He Z, et al. CACA guidelines for holistic integrative management of prostate cancer. Holist Integr Oncol. 2024;3:47.","journal-title":"Holist Integr Oncol"},{"key":"3867_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O. On respiratory impairment in cancer cells. Science. 1956;124:269\u201370.","journal-title":"Science"},{"key":"3867_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4161\/cbt.12.12.18367","volume":"12","author":"LC Costello","year":"2011","unstructured":"Costello LC, Franklin RB, Zou J, Feng P, Bok R, Swanson MG, et al. Human prostate cancer ZIP1\/zinc\/citrate genetic\/metabolic relationship in the TRAMP prostate cancer animal model. Cancer Biol Ther. 2011;12:1078\u201384.","journal-title":"Cancer Biol Ther"},{"key":"3867_CR6","doi-asserted-by":"publisher","first-page":"28875","DOI":"10.1074\/jbc.272.46.28875","volume":"272","author":"LC Costello","year":"1997","unstructured":"Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem. 1997;272:28875\u201381.","journal-title":"J Biol Chem"},{"key":"3867_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-17","volume":"5","author":"LC Costello","year":"2006","unstructured":"Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer: zinc and tumor suppression: connecting the dots. Mol Cancer. 2006;5:17.","journal-title":"Mol Cancer"},{"key":"3867_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.mam.2012.11.007","volume":"34","author":"MC Franz","year":"2013","unstructured":"Franz MC, Anderle P, Burzle M, Suzuki Y, Freeman MR, Hediger MA, et al. Zinc transporters in prostate cancer. Mol Asp Med. 2013;34:735\u201341.","journal-title":"Mol Asp Med"},{"key":"3867_CR9","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.7150\/thno.58729","volume":"11","author":"MJ Wu","year":"2021","unstructured":"Wu MJ, Chen CJ, Lin TY, Liu YY, Tseng LL, Cheng ML, et al. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. Theranostics. 2021;11:7779\u201396.","journal-title":"Theranostics"},{"key":"3867_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ptr.7631","volume":"37","author":"C Hu","year":"2023","unstructured":"Hu C, Xu H, Li Z, Liu D, Zhang S, Fang F, et al. Juglone promotes antitumor activity against prostate cancer via suppressing glycolysis and oxidative phosphorylation. Phytother Res. 2023;37:515\u201326.","journal-title":"Phytother Res"},{"key":"3867_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/antiox10101591","volume":"10","author":"S Ossikbayeva","year":"2021","unstructured":"Ossikbayeva S, Khanin M, Sharoni Y, Trachtenberg A, Tuleukhanov S, Sensenig R, et al. Curcumin and carnosic acid cooperate to inhibit proliferation and alter mitochondrial function of metastatic prostate cancer cells. Antioxidants. 2021;10:1591.","journal-title":"Antioxidants"},{"key":"3867_CR12","first-page":"269","volume":"16","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, He J, Zhang B, Wang L, Long C, Zhao B, et al. A potential \u201cAnti-Warburg Effect\u201d in circulating tumor cell-mediated metastatic progression? Aging Dis. 2024;16:269\u201382.","journal-title":"Aging Dis"},{"key":"3867_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18:31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3867_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108544","volume":"33","author":"B Rong","year":"2020","unstructured":"Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y, et al. Ribosome 18S m(6)A methyltransferase METTL5 promotes translation initiation and breast cancer cell growth. Cell Rep. 2020;33:108544.","journal-title":"Cell Rep"},{"key":"3867_CR15","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1016\/j.ymthe.2023.09.014","volume":"31","author":"Z Dai","year":"2023","unstructured":"Dai Z, Zhu W, Hou Y, Zhang X, Ren X, Lei K, et al. METTL5-mediated 18S rRNA m(6)A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Mol Ther. 2023;31:3225\u201342.","journal-title":"Mol Ther"},{"key":"3867_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","volume":"4","author":"H Peng","year":"2022","unstructured":"Peng H, Chen B, Wei W, Guo S, Han H, Yang C, et al. N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022;4:1041\u201354.","journal-title":"Nat Metab"},{"key":"3867_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cac2.12403","volume":"43","author":"P Xia","year":"2023","unstructured":"Xia P, Zhang H, Lu H, Xu K, Jiang X, Jiang Y, et al. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Commun. 2023;43:338\u201364.","journal-title":"Cancer Commun"},{"key":"3867_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41420-024-02166-1","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Yang G, Ma L, Tang B, Tao T. N(6)-methyladenosine (m(6)A) writer METTL5 represses the ferroptosis and antitumor immunity of gastric cancer. Cell Death Discov. 2024;10:402.","journal-title":"Cell Death Discov"},{"key":"3867_CR19","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82:2344\u201353.","journal-title":"Cancer Res"},{"key":"3867_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2018.02.036","volume":"173","author":"RK Khajuria","year":"2018","unstructured":"Khajuria RK, Munschauer M, Ulirsch JC, Fiorini C, Ludwig LS, McFarland SK, et al. Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell. 2018;173:90\u2013103 e119.","journal-title":"Cell"},{"key":"3867_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1236923","volume":"14","author":"W Ma","year":"2023","unstructured":"Ma W, Huang G, Wang Z, Wang L, Gao Q. IRF7: role and regulation in immunity and autoimmunity. Front Immunol. 2023;14:1236923.","journal-title":"Front Immunol"},{"key":"3867_CR22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772\u20137.","journal-title":"Nature"},{"key":"3867_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7150\/ijbs.65255","volume":"18","author":"Z Li","year":"2022","unstructured":"Li Z, Geng M, Ye X, Ji Y, Li Y, Zhang X, et al. IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma. Int J Biol Sci. 2022;18:30\u201342.","journal-title":"Int J Biol Sci"},{"key":"3867_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/nar\/gkz1101","volume":"48","author":"L Zheng","year":"2020","unstructured":"Zheng L, Meng Y, Campbell JL, Shen B. Multiple roles of DNA2 nuclease\/helicase in DNA metabolism, genome stability and human diseases. Nucleic Acids Res. 2020;48:16\u201335.","journal-title":"Nucleic Acids Res"},{"key":"3867_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45350-8","volume":"15","author":"N Thongon","year":"2024","unstructured":"Thongon N, Ma F, Baran N, Lockyer P, Liu J, Jackson C, et al. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nat Commun. 2024;15:1203.","journal-title":"Nat Commun"},{"key":"3867_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.molcel.2008.09.024","volume":"32","author":"L Zheng","year":"2008","unstructured":"Zheng L, Zhou M, Guo Z, Lu H, Qian L, Dai H, et al. Human DNA2 is a mitochondrial nuclease\/helicase for efficient processing of DNA replication and repair intermediates. Mol Cell. 2008;32:325\u201336.","journal-title":"Mol Cell"},{"key":"3867_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41420-024-02029-9","volume":"10","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yang H, Gan S, He L, Zeng R, Xiao T, et al. A novel mutation of DNA2 regulates neuronal cell membrane potential and epileptogenesis. Cell Death Discov. 2024;10:259.","journal-title":"Cell Death Discov"},{"key":"3867_CR28","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.cmet.2021.06.013","volume":"33","author":"S Liu","year":"2021","unstructured":"Liu S, Fu S, Wang G, Cao Y, Li L, Li X, et al. Glycerol-3-phosphate biosynthesis regenerates cytosolic NAD(+) to alleviate mitochondrial disease. Cell Metab. 2021;33:1974\u201387 e1979.","journal-title":"Cell Metab"},{"key":"3867_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41422-020-0372-z","volume":"31","author":"J Liu","year":"2021","unstructured":"Liu J, Peng Y, Shi L, Wan L, Inuzuka H, Long J, et al. Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle. Cell Res. 2021;31:80\u201393.","journal-title":"Cell Res"},{"key":"3867_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, Guo S, Wang S, Zhang Y, Chen H, Wang Y, et al. EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling. Cancer Res. 2022;82:831\u201345.","journal-title":"Cancer Res"},{"key":"3867_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15237-5","volume":"11","author":"B Schopf","year":"2020","unstructured":"Schopf B, Weissensteiner H, Schafer G, Fazzini F, Charoentong P, Naschberger A, et al. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nat Commun. 2020;11:1487.","journal-title":"Nat Commun"},{"key":"3867_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22652-9","volume":"12","author":"CL Chen","year":"2021","unstructured":"Chen CL, Hsu SC, Chung TY, Chu CY, Wang HJ, Hsiao PW, et al. Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells. Nat Commun. 2021;12:2398.","journal-title":"Nat Commun"},{"key":"3867_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-05661-6","volume":"614","author":"CR Bartman","year":"2023","unstructured":"Bartman CR, Weilandt DR, Shen Y, Lee WD, Han Y, TeSlaa T, et al. Slow TCA flux and ATP production in primary solid tumours but not metastases. Nature. 2023;614:349\u201357.","journal-title":"Nature"},{"key":"3867_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"3867_CR35","doi-asserted-by":"publisher","first-page":"e176736","DOI":"10.1172\/JCI176736","volume":"134","author":"K Vasan","year":"2024","unstructured":"Vasan K, Chandel NS. Molecular and cellular mechanisms underlying the failure of mitochondrial metabolism drugs in cancer clinical trials. J Clin Invest. 2024;134:e176736.","journal-title":"J Clin Invest"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03867-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:02:33Z","timestamp":1787004153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03867-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":35,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026,9,8]]}},"alternative-id":["3867"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03867-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}